Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Vinci Compass Investments Ltd
VINP
$758M
| $896K | ﹤0.01% |
84,900
+9,264
| +12% | +$111K |
2022 Q2
15 quarters
|
|
2327
Solid Biosciences
SLDB
$737M
| $895K | ﹤0.01% |
124,272
+71,472
| +135% | +$459K |
2025 Q3
2 quarters
|
|
2328
Ethos Technologies Inc
LIFE
$2.36B
| $894K | ﹤0.01% |
+80,000
| New | +$946K |
2026 Q1
0 quarters
|
|
2329
Accuray
ARAY
$27.4M
| $889K | ﹤0.01% |
2,290,984
-161,623
| -7% | -$99.8K |
2013 Q4
49 quarters
|
|
2330
Universal Electronics
UEIC
$69.1M
| $889K | ﹤0.01% |
215,723
+3,071
| +1% | +$12.2K |
2018 Q4
29 quarters
|
|
2331
DELISTED
Open Lending Corp
LPRO
| $886K | ﹤0.01% |
708,825
-36,371
| -5% | -$57.5K |
2021 Q3
18 quarters
|
|
2332
PagSeguro Digital
PAGS
$3.08B
| $883K | ﹤0.01% |
+88,157
| New | +$919K |
2026 Q1
0 quarters
|
|
2333
U.S. Small Cap Portfolio ETF Class Shares
DFAS
$15B
| $882K | ﹤0.01% |
+12,400
| New | +$910K |
2026 Q1
0 quarters
|
|
2334
51Talk Online Education Group
COE
$73.4M
| $882K | ﹤0.01% |
44,275
-1,900
| -4% | -$47.7K |
2019 Q1
28 quarters
|
|
2335
Peoples Financial Services
PFIS
$673M
| $881K | ﹤0.01% |
16,527
-3,800
| -19% | -$200K |
2015 Q3
42 quarters
|
|
2336
Neurogene
NGNE
$528M
| $875K | ﹤0.01% |
43,400
+29,400
| +210% | +$569K |
2025 Q4
1 quarter
|
|
2337
First Bank
FRBA
$433M
| $873K | ﹤0.01% |
54,588
-2,068
| -4% | -$33.9K |
2016 Q4
37 quarters
|
|
2338
ProFrac Holding
ACDC
$843M
| $872K | ﹤0.01% |
+140,700
| New | +$754K |
2026 Q1
0 quarters
|
|
2339
Manhattan Bridge Capital
LOAN
$39.2M
| $872K | ﹤0.01% |
196,018
+14,290
| +8% | +$63.6K |
2014 Q4
45 quarters
|
|
|
WSR
2340
DELISTED
Whitestone REIT
WSR
| $869K | ﹤0.01% |
53,811
-64,489
| -55% | -$971K |
2013 Q4
49 quarters
|
|
2341
iShares Core High Dividend ETF
HDV
$14.9B
| $869K | ﹤0.01% |
32,000
-32,500
| -50% | -$865K |
2025 Q3
2 quarters
|
|
2342
Citizens
CIA
$176M
| $868K | ﹤0.01% |
172,494
-3,100
| -2% | -$16.5K |
2018 Q3
30 quarters
|
|
2343
Trueblue
TBI
$270M
| $864K | ﹤0.01% |
220,934
+124,334
| +129% | +$552K |
2025 Q2
3 quarters
|
|
2344
SEACOR Marine Holdings
SMHI
$233M
| $862K | ﹤0.01% |
120,400
+2,100
| +2% | +$14.8K |
2020 Q4
21 quarters
|
|
2345
Eve Holding
EVEX
$582M
| $854K | ﹤0.01% |
+344,223
| New | +$1.18M |
2026 Q1
0 quarters
|
|
2346
Outset Medical
OM
$76.1M
| $853K | ﹤0.01% |
222,075
+176,870
| +391% | +$725K |
2024 Q3
6 quarters
|
|
2347
Avidia Bancorp
AVBC
$404M
| $852K | ﹤0.01% |
43,300
+31,100
| +255% | +$572K |
2025 Q4
1 quarter
|
|
2348
Blink Charging
BLNK
$67.4M
| $851K | ﹤0.01% |
1,501,600
-1,051,884
| -41% | -$741K |
2025 Q3
2 quarters
|
|
2349
Anavex Life Sciences
AVXL
$138M
| $850K | ﹤0.01% |
276,800
+251,378
| +989% | +$1.09M |
2025 Q4
1 quarter
|
|
2350
Core Laboratories
CLB
$463M
| $850K | ﹤0.01% |
50,603
-132,797
| -72% | -$2.38M |
2025 Q3
2 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.